MedTrace Logo

HPV-based Screening Among Women 23-29 Years of Age

NCT05229679 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180000

Last updated 2025-03-19

No results posted yet for this study

Summary

The aim of the trial is to determine whether organized screening with primary HPV analysis provide higher cancer protection in the age group 23-29 years compared to primary cytology.

Conditions

Interventions

DIAGNOSTIC_TEST

HPV testing

All women age 23-29 resident in the pilot counties will be invited to HPV screening as of the study start date. The same invitation as currently used for women aged 30 and upwards will be used. This information clearly states that it is possible to opt out of the program and that data from the screening program will be collected to regional and national quality registers who will systematically evaluate the quality of the care. At the screening station, the samples are collected identically regardless of primary screening test used - there is no change in the procedures used neither for the woman or for the midwives taking the sample. HPV testing will be performed using the same purchased, CE-marked and accredited HPV screening platforms as currently used for women aged 30 and upwards. The cytology is according to the liquid-based cytology method.

Sponsors & Collaborators

Principal Investigators

  • Joakim Dillner, MD, PhD · Karolinska University Hospital/Karolinska Institutet

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
23 Years
Max Age
29 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-16
Primary Completion
2038-12-31
Completion
2038-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05229679 on ClinicalTrials.gov